Effects of sodium‐glucose cotransporter 2 inhibitor, tofogliflozin, on the indices of renal tubular function in patients with type 2 diabetes

AIMS: Little is known of the effect of sodium‐glucose cotransporter 2 (SGLT2) inhibitors on the renal tubules. We investigated the effect of the SGLT2 inhibitor, tofogliflozin (TOFO) on renal tubular indices, according to the degree of albuminuria, in type 2 diabetes mellitus (T2DM) patients with pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Nunoi, Kiyohide, Sato, Yuichi, Kaku, Kohei, Yoshida, Akihiro, Suganami, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354802/
https://www.ncbi.nlm.nih.gov/pubmed/30815551
http://dx.doi.org/10.1002/edm2.15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354802/
https://www.ncbi.nlm.nih.gov/pubmed/30815551
http://dx.doi.org/10.1002/edm2.15

Ejemplares similares